Research Appraisalobservational

Explainable machine learning integrating bioelectrical impedance for 6-month cardiovascular risk in peritoneal dialysis

Renal failureTsai, Yi Liang, Wu, Chia Lin, Chiang, Jung Hsien1 Dec 2026DOI

Clinical Snapshot

65CEBM
Evidence: Moderateobservational

PICO Framework

P — PopulationClinically stable peritoneal dialysis patients with end-stage renal disease
I — InterventionMachine learning model using bioelectrical impedance spectroscopy (BIS) measurements and medical history
C — ComparatorModels using only medical history features versus models with BIS features
O — OutcomesMajor adverse cardiovascular events (MACEs) within 6 months

Bottom Line

This prognostic study developed a machine learning model combining bioelectrical impedance spectroscopy with medical history to predict 6-month cardiovascular events in peritoneal dialysis patients. The random forest model achieved good discrimination (AUC 0.88) and demonstrated that BIS measurements significantly improved sensitivity from 68% to 84% compared to medical history alone. However, the study lacks external validation, detailed patient characteristics, and comparison with existing risk tools. While the integration of BIS data shows promise for enhancing cardiovascular risk prediction in this high-risk population, clinicians should await external validation studies before routine implementation. The approach may be particularly valuable in centres already using BIS for fluid management, potentially providing dual utility for both volume assessment and cardiovascular risk stratification in PD patients.

Evidence: Moderate

Key Findings

  • P Value: Not reported in abstract

  • Effect Size: AUC = 0.88 for random forest model

  • Primary Outcome: Major adverse cardiovascular events within 6 months

  • Nnt Or Sensitivity: Sensitivity 0.84 with BIS integration (improved from 0.68 with medical history alone)

  • Confidence Interval: Not reported in abstract

Clinical Application

Moderate - requires BIS equipment and trained personnel, but uses clinically accessible features Relevant to Australian nephrology practice where PD is established treatment; BIS increasingly available in major dialysis centres; aligns with Kidney Health Australia guidelines for cardiovascular risk management in CKD Clinically stable peritoneal dialysis patients in tertiary care settings with access to bioelectrical impedance spectroscopy

Abstract

Peritoneal dialysis (PD) is a common treatment for end-stage renal disease, yet cardiovascular disease (CVD) remains a major cause of morbidity. Inadequate fluid management can elevate CVD risk, and bioelectrical impedance spectroscopy (BIS) is increasingly used to assess fluid status. This study aimed to develop an artificial intelligence model integrating BIS measurements and medical history to predict major adverse cardiovascular events (MACEs) within six months in clinically stable PD patients. Data were stratified by MACE occurrence and subject, with 80% assigned to training and 20% to testing. Class imbalance was addressed using the synthetic minority over-sampling technique. Four algorithms - logistic regression, random forest, XGBoost, and deep neural networks - were trained using fivefold cross-validation and grid search for optimal hyperparameters. Model performance was evaluated with area under the ROC curve (AUC), calibration plots, and decision curve analysis (DCA). Feature ablation experiments compared models using all 15 features, only 11 BIS-recorded features, and only 4 medical history features. The random forest model achieved the highest performance (AUC = 0.88), with CVD history as the most influential predictor. Isotonic regression calibration improved probability alignment (brier score = 0.0451). DCA suggested potential clinical benefit. While the model relied on four medical history features, its initial sensitivity was modest (0.68). Integrating BIS features significantly enhanced diagnostic sensitivity (0.84). The random forest model, based on 15 clinically accessible features, accurately predicts the risk of MACE within six months in clinically stable PD patients, demonstrating strong discriminatory ability with a performance reaching 88%.

References

  1. 1.Tsai, Y. L., Wu, C. L., & Chiang, J. H. (2026). Explainable machine learning integrating bioelectrical impedance for 6-month cardiovascular risk in peritoneal dialysis. Renal Failure, 48(1). https://doi.org/10.1080/0886022X.2026.2660005
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service